William (Bill) Weiss is Director of PreClinical Services in the University of North Texas (UNT) System College of Pharmacy at the UNT Health Science Center in Fort Worth. There he uses his 40 years of experience and expertise in infectious disease research to direct the evaluations of antibacterial agents, including established models of both acute and chronic bacterial infections in several different animal species as well as pharmacokinetic studies and HPLC/LCMS analysis in collaboration with large pharmaceutical companies, the biotech industry as well as academia.

Prior to this, he was Director of Drug Evaluation at Cumbre Pharmaceuticals Inc. His responsibilities included animal efficacy models, pharmacology and all pre-clinical microbiology research and development efforts focused on the discovery and development of new antimicrobial agents.

Previously, he has been a group leader in infectious disease discovery research and has held various positions of responsibility in antibacterial, antiviral and antifungal discovery research. He has worked on numerous antibacterial programmes including the development of the marketed products Suprax, Zosyn and Tygacil.

His expertise encompasses the development and evaluation of animal models of infectious disease as well as pharmacokinetic and pharmacodynamic analysis. He has authored or co-authored over 90 research presentations and journal articles.